Skip to main content
Premium Trial:

Request an Annual Quote

On the Bright Side: Innovation and a Move to Open Source

Over at O'Reilly Radar, Nat Torkington blogs about his view on the economic slump. In short, he's optimistic that the recession will help both science and the open source movement. In good times, he says, companies innovate less and duplicate other efforts more; "this recession will be good for innovation," he writes. As for open source, Torkington says having less money will inevitably drive people to use free software and operating systems. "The saying I use is, 'come for the price, stay for the quality,'" he adds.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.